Keyton Weissinger to Drive Patient Engagement Innovation for Standard Register Healthcare


Keyton Weissinger to Drive Patient Engagement Innovation for Standard Register Healthcare

Patient-centric communications to be a key focus of business' strategic direction

DAYTON, Ohio--(BUSINESS WIRE)-- Standard Register Healthcare, a business unit of Standard Register (NYS: SR) and a leader in managing critical communications for healthcare, has promoted Keyton Weissinger to the newly created position of vice president of innovation in which his first priority will be enhancing efforts to bring new solutions to market that drive patient engagement.

Keyton Weissinger (Photo: Business Wire)
Keyton Weissinger (Photo: Business Wire)

Keyton Weissinger (Photo: Business Wire)

"Legislative initiatives have made patient engagement a central focus for providers and payers," said John King, president of Standard Register Healthcare. "Keyton brings the energy, vision and experience that are vital to developing patient-centric communication tools to engage patients more fully and effectively in their care."

A self-described evangelist for healthcare transformation, Weissinger is a 20-year veteran of information technology with 10 years of experience in healthcare at both large corporations and entrepreneurial startups.

Prior to this promotion, he was vice president of technical operations for Dialog Medical, which Standard Register acquired in 2010. There, he was responsible for the management and day-to-day leadership of software development, implementation and customer service. He led the development of the iMedConsent™ application, a robust patient engagement solution that supports informed consent, discharge and patient education.

Originally a software developer, he went on to hold management positions at Arthur Andersen Business Consulting and a hospitality startup which took property management to the cloud for the first time.

Weissinger is author of dozens of scholarly articles and two technology books, including one that was published internationally in eight languages. He regularly shares his insights on Twitter @PatientEngaged.

Weissinger will be participating at the Strategic Partner Forum at HIMSS13 in New Orleans on March 3.

About Standard Register
Standard Register (NYS: SR) , celebrating 100 years of innovation, is trusted by the world's leading companies to advance their reputations by aligning their communications with corporate standards and priorities. Providing market-specific insights and a compelling portfolio of solutions to address the changing business landscape in commercial, healthcare, financial services and industrial markets, Standard Register is the recognized leader in the management and execution of mission-critical communications. More information is available at

Standard Register Healthcare is a business unit of Standard Register, serving more than 3,100 clients from across the healthcare delivery network, including acute, ambulatory, and long-term care, managed care and the suppliers that support them. A recognized leader in managing critical information and communications, Standard Register Healthcare, together with Dialog Medical, a subsidiary of Standard Register, provides industry-leading technology, solutions and services to accelerate performance, attract and educate patients, enhance safety and support patient-centered care. More information is available at

Photos/Multimedia Gallery Available:

Standard Register Healthcare
Media contact:
Christine Winters, 937-221-1804
Standard Register
Investor contact:
Carol Merry, 614-383-1624

KEYWORDS: United States North America Louisiana Ohio


The article Keyton Weissinger to Drive Patient Engagement Innovation for Standard Register Healthcare originally appeared on

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.